Kevin M.  Ban net worth and biography

Kevin Ban Biography and Net Worth

Kevin Ban, M.D., is the Executive Vice President and Global Chief Medical Officer for Walgreens Boots Alliance, Inc. After joining Walgreens as Chief Medical Officer in January 2020, he played an integral role in leading the company’s national pandemic response and defining its healthcare strategy. With over 25 years of clinical and administrative experience in the United States and abroad, Dr. Ban has deep experience in academic clinical medicine, population health and healthcare technology.  

Dr. Ban trained at Beth Israel Deaconess Medical Center (BIDMC) Harvard Affiliated Emergency Medicine Residency in Boston where he continued his career as an academic attending at Harvard Medical School. In the early part of his career, he worked on a joint venture between Harvard Medical International and the Tuscan government in Italy to standardize emergency medical care delivery and to establish Italy’s first pediatric trauma center. He brought key principles home from his experience abroad to Boston where he served as Chief Medical Officer within the BIDMC system focusing on population health management and clinical care delivery to drive improved outcomes. Later, he joined athenahealth leading and growing their population health technology and services across the country and later became their Chief Medical Officer. 

He graduated from Georgetown University with a B.A. in theology and later completed his M.D. from Georgetown’s School of Medicine. Dr. Ban completed two years of general surgery residency at Thomas Jefferson University Hospital in Philadelphia. 

What is Kevin M. Ban's net worth?

The estimated net worth of Kevin M. Ban is at least $494,113.20 as of November 18th, 2022. Dr. Ban owns 27,916 shares of Walgreens Boots Alliance stock worth more than $494,113 as of April 27th. This net worth estimate does not reflect any other assets that Dr. Ban may own. Learn More about Kevin M. Ban's net worth.

How do I contact Kevin M. Ban?

The corporate mailing address for Dr. Ban and other Walgreens Boots Alliance executives is 108 Wilmot Road, Deerfield IL, 60015. Walgreens Boots Alliance can also be reached via phone at (847) 315-3700 and via email at [email protected]. Learn More on Kevin M. Ban's contact information.

Has Kevin M. Ban been buying or selling shares of Walgreens Boots Alliance?

Kevin M. Ban has not been actively trading shares of Walgreens Boots Alliance over the course of the past ninety days. Most recently, Kevin M. Ban sold 10,303 shares of the business's stock in a transaction on Friday, November 18th. The shares were sold at an average price of $40.19, for a transaction totalling $414,077.57. Following the completion of the sale, the executive vice president now directly owns 27,916 shares of the company's stock, valued at $1,121,944.04. Learn More on Kevin M. Ban's trading history.

Who are Walgreens Boots Alliance's active insiders?

Walgreens Boots Alliance's insider roster includes Kevin Ban (EVP), Ornella Barra (COO), Rosalind Brewer (CEO), John Driscoll (EVP), Richard Gates (SVP), Valerie Jarrett (Director), Marco Pagni (CAO), Nancy Schlichting (Director), Timothy Wentworth (CEO), and Kathleen Wilson-Thompson (EVP). Learn More on Walgreens Boots Alliance's active insiders.

Are insiders buying or selling shares of Walgreens Boots Alliance?

During the last twelve months, Walgreens Boots Alliance insiders bought shares 5 times. They purchased a total of 28,628 shares worth more than $659,610.88. During the last twelve months, insiders at the pharmacy operator sold shares 2 times. They sold a total of 16,209 shares worth more than $371,017.45. The most recent insider tranaction occured on April, 11th when Director Inderpal S Bhandari bought 3,000 shares worth more than $54,150.00. Insiders at Walgreens Boots Alliance own 17.4% of the company. Learn More about insider trades at Walgreens Boots Alliance.

Information on this page was last updated on 4/11/2024.

Kevin M. Ban Insider Trading History at Walgreens Boots Alliance

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2022Sell10,303$40.19$414,077.5727,916View SEC Filing Icon  
See Full Table

Kevin M. Ban Buying and Selling Activity at Walgreens Boots Alliance

This chart shows Kevin M Ban's buying and selling at Walgreens Boots Alliance by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Walgreens Boots Alliance Company Overview

Walgreens Boots Alliance logo
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Read More

Today's Range

Now: $17.70
Low: $17.49
High: $17.95

50 Day Range

MA: $20.01
Low: $17.59
High: $22.31

2 Week Range

Now: $17.70
Low: $17.49
High: $35.38

Volume

6,592,036 shs

Average Volume

13,083,050 shs

Market Capitalization

$15.27 billion

P/E Ratio

N/A

Dividend Yield

5.68%

Beta

0.73